Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Cardiac arrhythmia; TAA/Tachyarrhythmia absoluta; Tachycardia induced cardiomyopathy; atrial fibrillation; pleural effusion; myocardial decompensation; Ascites; edema of legs; This is a spontaneous report from a non-contactable physician. This is a report received from the regulatory authority-WEB. Regulatory authority or other manufacturer number DE-PEI-PEI2021003141. A 38-year-old female patient received BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ6788), via an unspecified route of administration on 10Feb2021 at a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 13Feb2021 after vaccination, the patient developed myocardial decompensation, edema of legs, ascites, pleural effusion. On 21Feb2021, the patient experienced cardiac arrhythmia, tachyarrhythmia absoluta, atrial fibrillation and tachycardia induced cardiomyopathy, lasting for unknown. The patient is dead, was hospitalized and condition was life threatening. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on an unspecified date. The patient was treated with manual: therapy, e.g. antiphlogistic drugs. The patient died on an unspecified date. It was not reported if an autopsy was performed. The patient died due to the reported events. The outcome of the events was fatal. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: myocardial decompensation; edema of legs; ascites; pleural effusion; cardiac arrhythmia; tachyarrhythmia absoluta; atrial fibrillation; tachycardia induced cardiomyopathy
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166